Literature DB >> 3180998

Gene synthesis by serial cloning of oligonucleotides.

M A Hayden1, W Mandecki.   

Abstract

A rapid and simple method of gene synthesis is presented. A gene is constructed by serial additions of individual gene fragments in the 5'----3' direction. The vector used as the synthesis vehicle contains a unique Bsm I site at the amino terminus of the lacZ gene. Plasmid linearized with Bsm I is recircularized in vivo by oligonucleotide-directed double-strand break repair. The synthetic oligonucleotide used to "bridge" the double-strand break carries a 70- to 100-nucleotide insert which constitutes a portion of the gene along with a BsmI site at the 3' end that regenerates the site and allows for another consecutive round of mutagenesis to extend the gene sequence. The process is repeated until the entire gene is assembled. The method uses the beta-galactosidase color assay as a means of screening for correct insert lengths. The only in vitro enzymatic step necessary is a single Bsm I restriction digest of plasmid DNA. No ligation reactions are required. Only one strand of a gene sequence needs to be synthesized chemically. The gene synthesis method presented here was used to construct the human anaphylatoxin complement factor C3a gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180998     DOI: 10.1089/dna.1.1988.7.571

Source DB:  PubMed          Journal:  DNA        ISSN: 0198-0238


  3 in total

1.  Protein fabrication automation.

Authors:  J Colin Cox; Janel Lape; Mahmood A Sayed; Homme W Hellinga
Journal:  Protein Sci       Date:  2007-01-22       Impact factor: 6.725

2.  Photoaffinity polyamines: sequence-specific interactions with DNA.

Authors:  L Xiao; R A Swank; H R Matthews
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

3.  Restriction enzyme body doubles and PCR cloning: on the general use of type IIs restriction enzymes for cloning.

Authors:  Eszter Tóth; Krisztina Huszár; Petra Bencsura; Péter István Kulcsár; Barbara Vodicska; Antal Nyeste; Zsombor Welker; Szilvia Tóth; Ervin Welker
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.